III. Antagonist's viewpoint

[1]  M. Packer,et al.  Survival in congestive heart failure during treatment with drugs with positive inotropic actions. , 1987, Circulation.

[2]  T. LeJemtel,et al.  Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. , 1986, Journal of the American College of Cardiology.

[3]  Katz Am.  Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. , 1986 .

[4]  E. Braunwald,et al.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. , 1986, The New England journal of medicine.

[5]  E. Braunwald,et al.  New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1. , 1986, The New England journal of medicine.

[6]  P. Serruys,et al.  Left ventricular function after oral milrinone in patients with congestive heart failure. A hemodynamic and angiographic study. , 1986 .

[7]  M. Pfeffer,et al.  Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. , 1985, Circulation.

[8]  D. Baim,et al.  Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. , 1985, Circulation.

[9]  B. Massie,et al.  Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. , 1985, Circulation.

[10]  D. Baim,et al.  Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. , 1984, Circulation.

[11]  M. Packer,et al.  Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. , 1984, Circulation.

[12]  R. Erbel,et al.  Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. , 1984, Circulation.

[13]  C. Liang,et al.  Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine. , 1984, Circulation.

[14]  R. Ferris,et al.  Effects of In Vivo β-Adrenoceptor Down‐Regulation on Cardiac Responses to Prenalterol and Pirbuterol , 1983, Journal of cardiovascular pharmacology.

[15]  C. Leier,et al.  Drug-induced conditioning in congestive heart failure. , 1982, Circulation.

[16]  E. Braunwald,et al.  Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. , 1981, The New England journal of medicine.

[17]  A. Katz.  A new inotropic drug: its promise and a caution. , 1978, The New England journal of medicine.